A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch

ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy Nathan Vastesaeger, Bert Vander Cruyssen, Juan Mulero, Jordi Gratacós Masmitjá, Pedro Zarco, Raquel Almodovar, Pilar Font, Xavier Juanola, Eduardo Collantes-Estevez

RESPONDIA. Ibero-American Spondyloarthropaties Registry: Portuguese Group Elsa Sousa, Miguel Sousa, Fernando Pimentel, Ana Filipa Mourão, Ana Rodrigues, Helena Santos, Viana Queiroz, Ana Teixeira, Jaime Branco, Anabela Barcelos